- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (708)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (108)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (4)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (286)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (168)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (8)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (622)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (222)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (874)
- Research (386)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (596)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (324)
- Symptoms (182)
- Treatment (1760)
Prostate cancer survivor: I’m grateful for treatment at MD Anderson
BY Ford Swift
2 minute read | Published October 06, 2022
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on October 06, 2022
My dad had prostate cancer when he was 66, so I never miss my annual physical and routine bloodwork.
In August 2021, when my prostate-specific antigen (PSA) test came back high, I found a local urologist and had a digital rectal exam, followed by an MRI. The MRI results showed abnormal concerns for cancer. So, on Jan. 11, 2022, I had a biopsy.
Two weeks later, I found out I had prostate cancer.
I remember feeling fear and panic. The urologist suggested I undergo surgery. He explained I could experience erectile dysfunction or urinary incontinence.
I knew then I wanted a second opinion at MD Anderson. If I was going to have surgery, I wanted it to be at MD Anderson for the best possible outcome.
Coming to MD Anderson for prostate cancer treatment
I had my first appointment at MD Anderson on March 2 with surgeon Brian Chapin, M.D., and radiation oncologist Quynh-Nhu Nguyen, M.D. MD Anderson’s expertise brought me relief. I had mentally prepared myself for surgery based on my research, but Dr. Nguyen told me I had other treatment options because I had early-stage localized prostate cancer.
Dr. Nguyen recommended a type of internal radiation called prostate brachytherapy using the MRI-assisted radiosurgery (MARS) technique under the care of Steven Frank, M.D.
Dr. Frank put me at ease and made me confident that MARS brachytherapy was the right treatment option for me when we met on April 20. He explained that the positive-contrast MRI marker technology developed at MD Anderson allows physicians to accurately locate the implanted seeds within the prostate. This helps make the delivery of the internal radiation treatment very precise.
Undergoing MARS brachytherapy treatment for prostate cancer
On May 25, I received the MARS brachytherapy implant during an outpatient procedure. Dr. Frank was very thorough and did an MRI after the procedure to make sure the treatment was delivered as planned.
Two days after the procedure, I was on the water surfing. I felt great. I had a burning sensation when I urinated for several weeks after the procedure. Dr. Frank prescribed an oral medication to help lessen this condition, which is resolving. Otherwise, my side effects were minimal.
Your PSA test: Keep score to help find cancer
I encourage other men to keep track of their PSA scores. If your numbers change from year to year, find a urologist. If you do not feel comfortable with the prognosis you are given, do your research. Be aware of the treatment options so you can find the right option for you if you are diagnosed with prostate cancer.
Request an appointment at MD Anderson online or by calling 1-877-755-1354.

Two days after the procedure, I was on the water surfing.
Ford Swift
Survivor
